Bartlett & Co. LLC Viatris Inc Transaction History

Bartlett & Co. LLC

$6.16 Billion
Q4 2023

A detailed history of Bartlett & Co. LLC transactions in Viatris Inc stock. As of the latest transaction made, Bartlett & Co. LLC holds 2,228 shares of VTRS stock, worth $28,964. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,228

Previous 5,432 58.98%

Holding current value

$28,964

Previous $54,000 55.56%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	SELL	$8.77 - $10.85 $28,099 - $34,763	-3,204 Reduced 58.98%	2,228 $24,000
Q3 2023 Oct 10, 2023	SELL	$9.59 - $11.35 $109,556 - $129,662	-11,424 Reduced 67.77%	5,432 $54,000
Q2 2023 Jul 14, 2023	BUY	$9.02 - $10.29 $108,817 - $124,138	12,064 Added 251.75%	16,856 $168,000
Q1 2023 Apr 06, 2023	SELL	$9.2 - $12.26 $29,918 - $39,869	-3,252 Reduced 40.43%	4,792 $46,000
Q4 2022 Jan 04, 2023	SELL	$8.72 - $11.56 $322 - $427	-37 Reduced 0.46%	8,044 $90,000
Q2 2022 Aug 02, 2022	SELL	$9.95 - $12.27 $1,432 - $1,766	-144 Reduced 1.75%	8,081 $85,000
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $23,004 - $36,113	-2,345 Reduced 22.19%	8,225 $89,000
Q4 2021 Mar 08, 2022	BUY	$12.09 - $14.68 $31,107 - $37,771	2,573 Added 32.17%	10,570 $143,000
Q3 2021 Oct 15, 2021	BUY	$13.25 - $15.13 $22,034 - $25,161	1,663 Added 26.26%	7,997 $108,000
Q2 2021 Jul 19, 2021	SELL	$12.97 - $16.15 $34,616 - $43,104	-2,669 Reduced 29.65%	6,334 $91,000
Q1 2021 Apr 19, 2021	SELL	$13.59 - $18.54 $98,432 - $134,285	-7,243 Reduced 44.58%	9,003 $126,000
Q4 2020 Jan 20, 2021	BUY	$14.3 - $18.74 $232,317 - $304,450	16,246 New	16,246 $304,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

934M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.

Account